279
Participants
Start Date
April 30, 2003
Primary Completion Date
December 31, 2004
Study Completion Date
December 31, 2004
Botulinum Toxin Type A
Each patient received from 1 to 5 treatments, with a minimum of 12 weeks between treatments. For each treatment, a total dose of 200 U to 400 U botulinum toxin Type A was injected into the wrist and finger flexor muscles of the affected upper limb, not to exceed 6 U/kg
Indianapolis
Vancouver
Lead Sponsor
Allergan
INDUSTRY